4 Mg Zoledronic Acid Injection

Name: 4 Mg Zoledronic Acid Injection
Brand: NEETCO BIOPHARMA
Price: 498 INR
Availability: InStock

Price 498 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

4 Mg Zoledronic Acid Injection Specification

Dosage Form
Injection

Indication
Treatment of hypercalcemia of malignancy, bone metastases in solid tumors, multiple myeloma, and Pagets disease of bone

Salt Composition
Zoledronic Acid 4 mg

Feature
Ready-to-use, single-dose vial

Ingredients
Zoledronic acid monohydrate, sterile water for injection, mannitol, sodium citrate

Application
IV infusion in hospital/clinical settings

Ph Level
Approximately 6.07.0

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from light

Shelf Life
24 months

About 4 Mg Zoledronic Acid Injection

Explore the dominant solution for advanced bone disorder management with 4 Mg Zoledronic Acid Injection, supplied in a world-class 5 ml single-dose glass vial. Developed by leading pharmaceutical companies, this celebrated USP-grade medication is indicated for hypercalcemia of malignancy, bone metastases in solid tumors, multiple myeloma, and Paget's disease. Administered intravenously under prescription, it features a clear, odorless, ready-to-use formulation. Bargain for the best with its extended 24-month shelf life and adherence to strict safety standards. Advance purchase is recommended for clinical settings. Dispose of unused medicine as per local regulations.

Primary Competitive Advantages & Usage Benefits

4 Mg Zoledronic Acid Injection offers prestigious USP pharmacopoeia grade quality and is ready-to-use in single-dose vials for hospital or clinical IV infusion. The injection is primarily used for the treatment of hypercalcemia of malignancy, bone metastases, multiple myeloma, and Paget's disease of bone. Its advanced formulation ensures precise dosing and minimal waste, making it ideal for prescription-based hospital settings. This product delivers reliability and safety for both healthcare providers and patients.

Certifications, Export Markets & Quotation/Shipping Details

4 Mg Zoledronic Acid Injection comes with recognized certifications that assure quality and compliance. Shipments are handled efficiently from a major FOB port in India, reaching clients across world-class markets such as Asia, Africa, the Middle East, and South America. Receive a quotation based on your order requirements, and benefit from the competitive sale price offered to distributors, traders, and exporters worldwide. Reliable delivery and certification make this a trusted pharmaceutical export product.

FAQ's of 4 Mg Zoledronic Acid Injection:

Q: How is the 4 Mg Zoledronic Acid Injection administered to patients?

A: This injection is administered only by intravenous (IV) infusion in hospital or clinical settings under professional supervision to ensure proper dosing and patient safety.

Q: What are the primary medical conditions treated with this injection?

A: The injection is indicated for the treatment of hypercalcemia of malignancy, bone metastases in solid tumors, multiple myeloma, and Paget's disease of bone.

Q: When should the product not be used or prescribed?

A: It should not be used in patients with hypersensitivity to zoledronic acid or other bisphosphonates, or in those with severe renal impairment.

Q: Where should the unused injection and waste materials be disposed of?

A: Unused medicine and waste material must be disposed of according to local regulations for pharmaceutical waste to ensure environmental safety.

Q: What are some benefits of advance purchasing this product?

A: Advance purchase ensures timely availability, especially for hospitals and clinics managing time-sensitive conditions. It also allows buyers to benefit from potential price advantages and guaranteed stock.

Q: What makes this zoledronic acid injection a competitive choice?

A: Its celebrated compatibility, single-dose ready-to-use vial, strict adherence to USP grade, and comprehensive export certifications position it as a dominant, reliable therapeutic agent in the pharmaceutical market.

Tell us about your requirement